Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-17
1989-06-13
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546290, 546301, 546302, 546303, A61K 3144, C07D21370
Patent
active
048393711
ABSTRACT:
Disclosed are novel substituted 3-aralkyl-2-mercaptopyridines of the structure: ##STR1## processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy in particular as dopamine-.beta.-hydroxylase inhibitors.
REFERENCES:
patent: 3853900 (1974-12-01), Shone
patent: 4487761 (1984-12-01), Cole et al.
patent: 4532331 (1985-07-01), Frazee et al.
Kruse Lawrence I.
Ross Stephen T.
Lourie Alan D.
McCarthy Mary E.
Northington Zinna
Schwartz Richard A.
SmithKline Beckman Corporation
LandOfFree
3-aralkyl-2-mercaptoyridines as dopamine-.beta.-hydroxylase inhi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aralkyl-2-mercaptoyridines as dopamine-.beta.-hydroxylase inhi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aralkyl-2-mercaptoyridines as dopamine-.beta.-hydroxylase inhi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1277944